Spinnovation Analytical receives GMP certification for testing drug substances and drug products
Spinnovation has been granted a certification of Good Manufacturing Practices (GMP) compliance by the Dutch Health Care Inspectorate. This certifies that Spinnovation is qualified to test pharmaceutical drug substances and products for market release. GMP certification is recognition of Spinnovation’s adherence to the highest quality management procedures and standards, and will support the company in delivering the QC testing services and analytical solutions for clients involved in the manufacturing and release of small molecule drugs and biologicals.
GMP certification will enable Spinnovation to extend its existing solutions based on its high-end analytical platform which notably includes Nuclear Magnetic Resonance (NMR), LC-MS, UPLC-MS/MS and ICP-OES. The platform has also recently been expanded and now also includes solid-state NMR and X-ray powder diffraction (XRPD) methods, to offer polymorphism/amorphization testing of solid-state drug substance and pharmaceutical formulations.
Other news from the department politics & laws
